APO RESEARCH · REPORT
Deoxyribonucleic Acid and Ribonucleic Acid Banking Services
Selected research
Industry Research
Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Industry Research Report 2026
Market perspective
The global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Deoxyribonucleic Acid and Ribonucleic Acid Banking Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Deoxyribonucleic Acid and Ribonucleic Acid Banking Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Deoxyribonucleic Acid and Ribonucleic Acid Banking Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Deoxyribonucleic Acid and Ribonucleic Acid Banking Services include Thermo Fisher Scientific, BioStorage Technologies Inc., Life Technologies, BGI Group, DNA Genotek, Hamilton Company, Integrated DNA Technologies, Promega Corporation and Qiagen N.V. and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Deoxyribonucleic Acid and Ribonucleic Acid Banking Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market by Company
Thermo Fisher Scientific
BioStorage Technologies Inc.
Life Technologies
BGI Group
DNA Genotek
Hamilton Company
Integrated DNA Technologies
Promega Corporation
Qiagen N.V.
Tecan Group Ltd.
Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Segment by Type
Transportation
Processing
Storage
Quality Control
Data Storage
Others
Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Segment by Application
Academic Research
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Others
Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Deoxyribonucleic Acid and Ribonucleic Acid Banking Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Deoxyribonucleic Acid and Ribonucleic Acid Banking Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Deoxyribonucleic Acid and Ribonucleic Acid Banking Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Transportation
- Processing
- Storage
- Quality Control
- Data Storage
- Others
Applications
- Academic Research
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Centers
- Others
Companies covered
- Thermo Fisher Scientific
- BioStorage Technologies Inc.
- Life Technologies
- BGI Group
- DNA Genotek
- Hamilton Company
- Integrated DNA Technologies
- Promega Corporation
- Qiagen N.V.
- Tecan Group Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Transportation
- 2.2.3 Processing
- 2.2.4 Storage
- 2.2.5 Quality Control
- 2.2.6 Data Storage
- 2.2.7 Others
- 2.3 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Academic Research
- 2.3.3 Pharmaceutical & Biotechnology Companies
- 2.3.4 Hospitals & Diagnostic Centers
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Breakdown Data by Type
- 3.1 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Historic Market Size by Type (2021-2026)
- 3.2 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Forecasted Market Size by Type (2027-2032)
4 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Breakdown Data by Application
- 4.1 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Historic Market Size by Application (2021-2026)
- 4.2 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Perspective (2021-2032)
- 5.2 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Growth Trends by Region
- 5.2.1 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Historic Market Size by Region (2021-2026)
- 5.2.3 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Forecasted Market Size by Region (2027-2032)
- 5.3 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Dynamics
- 5.3.1 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Industry Trends
- 5.3.2 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Drivers
- 5.3.3 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Challenges
- 5.3.4 Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Players by Revenue
- 6.1.1 Global Top Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Players by Revenue (2021-2026)
- 6.1.2 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Head Office and Area Served
- 6.4 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Players, Product Type & Application
- 6.5 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Manufacturers Established Date
- 6.6 Global Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size (2021-2032)
- 7.2 North America Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size by Country (2021-2026)
- 7.4 North America Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size (2021-2032)
- 8.2 Europe Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size by Country (2021-2026)
- 8.4 Europe Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size (2021-2032)
- 9.2 Asia-Pacific Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size (2021-2032)
- 10.2 South America Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size by Country (2021-2026)
- 10.4 South America Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size (2021-2032)
- 11.2 Middle East & Africa Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific
- 12.1.1 Thermo Fisher Scientific Company Information
- 12.1.2 Thermo Fisher Scientific Business Overview
- 12.1.3 Thermo Fisher Scientific Revenue in Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
- 12.1.5 Thermo Fisher Scientific Recent Developments
- 12.2 BioStorage Technologies Inc.
- 12.2.1 BioStorage Technologies Inc. Company Information
- 12.2.2 BioStorage Technologies Inc. Business Overview
- 12.2.3 BioStorage Technologies Inc. Revenue in Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Business (2021-2026)
- 12.2.4 BioStorage Technologies Inc. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
- 12.2.5 BioStorage Technologies Inc. Recent Developments
- 12.3 Life Technologies
- 12.3.1 Life Technologies Company Information
- 12.3.2 Life Technologies Business Overview
- 12.3.3 Life Technologies Revenue in Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Business (2021-2026)
- 12.3.4 Life Technologies Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
- 12.3.5 Life Technologies Recent Developments
- 12.4 BGI Group
- 12.4.1 BGI Group Company Information
- 12.4.2 BGI Group Business Overview
- 12.4.3 BGI Group Revenue in Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Business (2021-2026)
- 12.4.4 BGI Group Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
- 12.4.5 BGI Group Recent Developments
- 12.5 DNA Genotek
- 12.5.1 DNA Genotek Company Information
- 12.5.2 DNA Genotek Business Overview
- 12.5.3 DNA Genotek Revenue in Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Business (2021-2026)
- 12.5.4 DNA Genotek Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
- 12.5.5 DNA Genotek Recent Developments
- 12.6 Hamilton Company
- 12.6.1 Hamilton Company Company Information
- 12.6.2 Hamilton Company Business Overview
- 12.6.3 Hamilton Company Revenue in Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Business (2021-2026)
- 12.6.4 Hamilton Company Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
- 12.6.5 Hamilton Company Recent Developments
- 12.7 Integrated DNA Technologies
- 12.7.1 Integrated DNA Technologies Company Information
- 12.7.2 Integrated DNA Technologies Business Overview
- 12.7.3 Integrated DNA Technologies Revenue in Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Business (2021-2026)
- 12.7.4 Integrated DNA Technologies Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
- 12.7.5 Integrated DNA Technologies Recent Developments
- 12.8 Promega Corporation
- 12.8.1 Promega Corporation Company Information
- 12.8.2 Promega Corporation Business Overview
- 12.8.3 Promega Corporation Revenue in Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Business (2021-2026)
- 12.8.4 Promega Corporation Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
- 12.8.5 Promega Corporation Recent Developments
- 12.9 Qiagen N.V.
- 12.9.1 Qiagen N.V. Company Information
- 12.9.2 Qiagen N.V. Business Overview
- 12.9.3 Qiagen N.V. Revenue in Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Business (2021-2026)
- 12.9.4 Qiagen N.V. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
- 12.9.5 Qiagen N.V. Recent Developments
- 12.10 Tecan Group Ltd.
- 12.10.1 Tecan Group Ltd. Company Information
- 12.10.2 Tecan Group Ltd. Business Overview
- 12.10.3 Tecan Group Ltd. Revenue in Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Business (2021-2026)
- 12.10.4 Tecan Group Ltd. Deoxyribonucleic Acid and Ribonucleic Acid Banking Services Product Portfolio
- 12.10.5 Tecan Group Ltd. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst